Filing Details
- Accession Number:
- 0001179110-20-009968
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-28 07:48:17
- Reporting Period:
- 2020-09-24
- Accepted Time:
- 2020-09-28 07:48:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1634432 | Strongbridge Biopharma Plc | SBBP | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1106519 | N David Gill | 900 Northbrook Drive Suite 200 Trevose PA 19053 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2020-09-24 | 8,000 | $2.13 | 74,896 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased on the open market in multiple transactions at prices ranging from $2.13 to $2.14, inclusive. The Reporting Person undertakes to provide to the Issuer, to any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.